High-throughput Sequencing to Identify Bacteremia in Children with Cancer.


Journal

The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858

Informations de publication

Date de publication:
01 08 2023
Historique:
pmc-release: 01 08 2024
medline: 21 7 2023
pubmed: 12 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

Current methods to diagnose bacteremia are limited. In this pilot study of children with cancer presenting with fever, we determined the concordance between a novel high-throughput sequencing platform called BacCapSeq and blood culture. High-throughput sequencing had modest concordance with blood culture. Discordant organisms included those with both unlikely or potential clinical relevance.

Identifiants

pubmed: 37171915
doi: 10.1097/INF.0000000000003948
pii: 00006454-202308000-00021
pmc: PMC10523992
mid: NIHMS1889726
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

695-697

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001873
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Freifeld AG, Bow EJ, Sepkowitz KA, et al.; Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56–e93.
Kelly MJ, Vivier PM, Panken TM, et al. Bacteremia in febrile nonneutropenic pediatric oncology patients. Pediatr Blood Cancer. 2010;54:83–87.
Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019;14:319–338.
Allicock OM, Guo C, Uhlemann AC, et al. BacCapSeq: a platform for diagnosis and characterization of bacterial infections. mBio. 2018;9:e02007−e02018.
Ye SH, Siddle KJ, Park DJ, et al. Benchmarking metagenomics tools for taxonomic classification. Cell. 2019;178:779–794.
McIntyre ABR, Ounit R, Afshinnekoo E, et al. Comprehensive benchmarking and ensemble approaches for metagenomic classifiers. Genome Biol. 2017;18:182.
Rossoff J, Chaudhury S, Soneji M, et al. Noninvasive diagnosis of infection using plasma next-generation sequencing: a single-center experience. Open Forum Infect Dis. 2019;6:ofz327.
Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018;66:778–788.
Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8:73.
Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol. 2019;4:663–674.

Auteurs

Son H McLaren (SH)

From the Division of Pediatric Emergency Medicine, Department of Emergency Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.

Nischay Mishra (N)

Department of Epidemiology, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY.

Nobuko Hijiya (N)

Division of Pediatric Hematology Oncology and Stem Cell Transplant, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.

James Ng (J)

Department of Epidemiology, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY.

Cheng Guo (C)

Department of Epidemiology, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY.

Susan Whittier (S)

Department of Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.

Erica Mariani (E)

Department of Pediatrics, New York University Langone Medical Center/Bellevue Hospital Center, New York, NY.

Laura Glaser (L)

Department of Pediatrics, Pediatric Hematology Oncology and Stem Cell Transplant Clinic, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY.

Irene Frantzis (I)

Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.

Marc T Vindas (MT)

The Cancer Center at Cooperman Barnabas Medical Center, Rutgers Cancer Institute of New Jersey, Livingston, NJ.

Cheng-Shiun Leu (CS)

Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.

Peter S Dayan (PS)

From the Division of Pediatric Emergency Medicine, Department of Emergency Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH